Flu Vaccines: Advancements, Challenges, and Global Impact – Expert Insights on Vaccine Platforms and Immune Responses
In this phenomenal episode, three leading experts in the field of vaccinology and immunology dive into the science behind various vaccine platforms and immune responses
Wrap up - Unpacking intervention strategies for acute respiratory viruses
Our distinguished experts and coalition partners unwrap and define key intervention strategies for ARVIs. Building on insights from previous episodes they offer fresh perspectives and bring to light the complexity of prevention, diagnostics and therapy.
Europe needs a sustainably funded influenza research and response network
Six ESWI Board Members, led by Prof. Florian Krammer, together with a long list of prominent European scientists specialised in virology, immunology and epidemiology, have recently published a commentary in The Lancet Infectious Diseases.
Participants will have the opportunity to attend lectures given by world renowned scientists in the field of pediatric infectious disease as well as genomics, pharmacology, immunology, gastrointestinal diseases, allergology and public health.
In 2023, Finland faced an outbreak of highly pathogenic avian influenza caused by clade 2.3.4.4b A(H5N1) viruses, which spread from wild birds to fur farms.
Human monoclonal antibodies that target clade 2.3.4.4b H5N1 hemagglutinin
The highly pathogenic avian influenza H5N1 virus clade 2.3.4.4b has been spreading globally since 2022, causing mortality and morbidity in domestic and wild birds and mammals, including infection in humans, raising concerns about its pandemic potential.
Government of Canada purchases avian influenza vaccine to protect individuals most at risk
The Public Health Agency of Canada (PHAC) and its partners are focused on keeping people and animals in Canada safe and ensuring Canada is ready for any potential health threats.
Pathogenesis of bovine H5N1 clade 2.3.4.4b infection in Macaques
Since early 2022 highly pathogenic avian influenza (HPAI) H5N1 virus infections have been reported in wild aquatic birds and poultry throughout the United States (US) with spillover into several mammalian species.
Influenza at the human-animal interface summary and assessment, 20 January 2025
From 13 December 2024 to 20 January 2025, the detection of influenza A(H5) virus in five humans, influenza A(H9N2) virus in two humans, and influenza A(H10N3) virus in one human were reported officially.
H5Nx viruses remain a threat to human health. Over the past few years, the H5Nx clade 2.3.4.4b has rapidly spread to 6 continents, leading to massive avian and mammalian host deaths.